D
Diederick E. Grobbee
Researcher at Utrecht University
Publications - 1108
Citations - 136069
Diederick E. Grobbee is an academic researcher from Utrecht University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 155, co-authored 1051 publications receiving 122748 citations. Previous affiliations of Diederick E. Grobbee include National Heart Foundation of Australia & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
Text-mining in electronic healthcare records for efficient recruitment and data-collection in cardiovascular trials: a multicenter validation study
Wouter B van Dijk,Aernoud T L Fiolet,Ewoud Schuit,Arjan Sammani,Katrien Groenhof,Rieke van der Graaf,Martine C. de Vries,Marco Alings,Jeroen Schaap,Folkert W. Asselbergs,Diederick E. Grobbee,Rolf H.H. Groenwold,Arend Mosterd +12 more
Journal ArticleDOI
Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States
Charisma Hehakaya,Ankur M. Sharma,J. van der Voort van Zijp,Diederick E. Grobbee,Helena M. Verkooijen,Enrique Izaguirre,Ellen H.M. Moors +6 more
TL;DR: In this paper , a case study of the US health care system with the use of the 1.5 Tesla Magnetic Resonance Linear Accelerator (MR-Linac) is presented.
Journal ArticleDOI
Views and preferences of medical professionals and pregnant women about a novel primary prevention intervention for hypertensive disorders of pregnancy: a qualitative study
A. Vestering,Mireille N. Bekker,Diederick E. Grobbee,R. van der Graaf,Arie Franx,Neeltje Crombag,Neeltje Crombag,Joyce L Browne +7 more
TL;DR: In general, women and healthcare practitioners expressed a positive attitude towards a polypill intervention as primary prevention strategy with aspirin and calcium, providing some conditions are met.
Journal ArticleDOI
Effects of recruitment strategies and demographic factors on inclusion in a large scale vaccination trial in adults 65 years and older
TL;DR: In this paper, the authors determined associations between patient related and study-related factors and study inclusion in healthy elderly (>65 years) invited to participate in a double-blind placebo-controlled randomized study to determine effectiveness and safety of a 13-valent pneumococcal vaccine for community-acquired pneumonia in the Netherlands.
Posted ContentDOI
Polygenic risk scores predict diabetic complications and their response to therapy
Johanne Tremblay,Mounsif Haloui,Francois Harvey,Ramzan Tahir,Francois-Christophe Marois-Blanchet,Carole Long,Redha Attaoua,Paul Simon,Lara Santucci,Candan Hizel,John Chalmers,Michel Marre,Stephen B. Harrap,Renata Cifkova,Alena Krajčoviechová,David R. Matthews,Bryan Williams,Neil R Poulter,Sophia Zoungas,Stephen Colagiuri,Giuseppe Mancia,Diederick E. Grobbee,Anthony Rodgers,Lisheng Liu,Mawusse Agbessi,Vanessa Bruat,Marie-Julie Favé,Michelle P Harwood,Philip Awadalla,Mark Woodward,Mark Woodward,Pavel Hamet +31 more
TL;DR: This novel polygenic prediction model identified people with diabetes at low and high risk of complications and improved targeting those at greater benefit from intensive therapy while avoiding unnecessary intensification in low-risk subjects.